You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative neoplasms/myelofibrosis

Showing 1 - 25 of 1,359
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

    Not yet recruiting
    • Myeloproliferative Disorders
    • +3 more
    • (no location specified)
    Nov 21, 2023

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

    Not yet recruiting
    • Bone Marrow Fibrosis
    • Myeloproliferative Neoplasm
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jan 30, 2023

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022

    Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

    Not yet recruiting
    • Myeloid Malignancy
    • +4 more
    • Telehealth Serious Illness Care Program
    • Education Control
    • Rochester, New York
      University of Rochester
    May 24, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

    Recruiting
    • Accelerated/Blast-phase Myeloproliferative Neoplasm
    • +2 more
    • Scottsdale, Arizona
    • +10 more
    May 9, 2022

    Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

    Recruiting
    • Myeloid Malignancy
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Jul 21, 2022

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

    Recruiting
    • Myeloproliferative Neoplasm
    • +5 more
    • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
    • Aspirin 81 mg
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Apr 19, 2022

    Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

    Enrolling by invitation
    • Thrombocythemia, Essential
    • Primary Myelofibrosis
    • Miami, Florida
    • +18 more
    Jan 30, 2023

    Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

    Active, not recruiting
    • Myelofibrosis
    • Chronic Myelomonocytic Leukemia
    • Duarte, California
    • +9 more
    Jan 24, 2023

    Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

    Active, not recruiting
    • Myelofibrosis
      • Firenze, FI, Italy
      • +5 more
      Nov 11, 2021

      Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

      Completed
      Has Results
      • Chronic Phase Myelofibrosis
      • +3 more
      • Boston, Massachusetts
      • +2 more
      May 27, 2021

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

      Completed
      • Primary Myelofibrosis
      • Anemia
      • Phoenix, Arizona
      • +24 more
      Aug 17, 2022

      Epigenetic Age on Clinic-biological Presentation and Prognosis

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Assessment of the epigenetic age
      • Bordeaux, France
        CHU de Bordeaux, service Hématologie Biologique
      Aug 28, 2023

      Myeloproliferative Tumors Trial (INCA033989)

      Not yet recruiting
      • Myeloproliferative Neoplasms
      • (no location specified)
      Sep 11, 2023